ZIOP - Why Shares of Ziopharm Oncology Jumped on Wednesday
Shares of Ziopharm Oncology (NASDAQ: ZIOP) rose more than 10% on Wednesday. The stock, which closed at $1.63 on Tuesday, opened at $1.65 on Wednesday and rose as high as $1.84 in midday trading. But it's still closer to its 52-week low of $1.26 than it is to its 52-week high of $5.95.
IMAGE SOURCE: GETTY IMAGES
Ziopharm stock had been on a steady slide, and is down by more than 23% this year. Investors were apparently encouraged by the appointment of a new CEO, Kevin S. Boyle, late Monday. Boyle previously was CEO of Kuur Therapeutics until that company was purchased by Athenex .
For further details see:
Why Shares of Ziopharm Oncology Jumped on Wednesday